Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 8.63B 1.29B 1.15B 1.07B 974M 1.83B 124B 1.85B 12.93B 5.03B 63.3B 4.83B 4.73B 203B P/E 2026 *
85.3x
P/E 2027 * 65.3x
Enterprise Value 8.63B 1.29B 1.15B 1.07B 974M 1.83B 124B 1.85B 12.93B 5.03B 63.3B 4.83B 4.73B 203B EV / Sales 2026 *
7.92x
EV / Sales 2027 * 6.97x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
09-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
08-24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
25-10-27 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-09 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
1 day-0.36%
1 week-1.77%
1 month-4.01%
3 months-35.44%
6 months+50.66%
Current year+89.09%
1 week 33.02
Extreme 33.02
34.97
1 month 30.59
Extreme 30.59
38.86
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 2024-04-14
Director of Finance/CFO 45 2022-11-28
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 68 2025-10-30
Director/Board Member 77 2024-04-14
Director/Board Member 60 2024-04-14
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-1.77%+93.38%+160.20% 1.29B
-0.14%-2.31%+2.20%-6.38% 19.34B
+0.31%+1.37%-22.33%+35.53% 17.65B
+1.31%-0.04%+13.65%+19.68% 14.92B
+0.08%-1.10%+4.01%-7.00% 12.87B
+0.50%-0.83%+10.53%+24.55% 11.4B
+0.45%-0.81%+21.26%+67.90% 11.28B
-1.63%-5.04%+3.25%-13.53% 8.89B
+0.58%-3.09%-9.47%-2.54% 7.62B
0.00%+0.16%+95.04%+930.95% 6.91B
Average +0.12%-1.84%+21.15%+120.94% 11.22B
Weighted average by Cap. +0.22%-0.85%+8.89%+73.56%

Financials

2026 *2027 *
Net sales 1.09B 163M 145M 135M 123M 232M 15.66B 233M 1.63B 635M 7.99B 610M 597M 25.69B 1.24B 185M 165M 153M 140M 263M 17.78B 265M 1.85B 721M 9.08B 693M 678M 29.17B
Net income 103M 15.36M 13.7M 12.77M 11.62M 21.88M 1.48B 22.04M 154M 60.02M 755M 57.67M 56.43M 2.43B 137M 20.43M 18.23M 16.98M 15.46M 29.1M 1.97B 29.32M 205M 79.84M 1B 76.71M 75.05M 3.23B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
26-09-30 CN¥33.28 -0.36% 12,506,092
26-09-29 CN¥33.40 -1.42% 11,055,616

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock